532167 OMKARPH

Omkar Pharmachem Share Price

 

 

Start SIP in OMKARPH

Start SIP

Performance

  • Low
  • ₹28
  • High
  • ₹28
  • 52 Week Low
  • ₹26
  • 52 Week High
  • ₹30
  • Open Price₹28
  • Previous Close₹28
  • Volume5

Investment Returns

  • Over 3 Month + 10.84%
  • Over 6 Month + 2.16%
  • Over 1 Year -2.28%

Smart Investing Starts Here Start SIP with Omkar Pharmachem for Steady Growth!

Invest Now

Omkar Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 203.1
  • PEG Ratio
  • -8.1
  • Market Cap Cr
  • 29
  • P/B Ratio
  • Average True Range
  • 0.51
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.22
  • RSI
  • 61.29
  • MFI
  • 84.31

Omkar Pharmachem Financials

Omkar Pharmachem Technicals

EMA & SMA

Current Price
₹28.33
0 (0%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹26.90
  • 50 Day
  • ₹26.37
  • 100 Day
  • ₹24.43
  • 200 Day
  • ₹20.30

Resistance and Support

28.33 Pivot Speed
  • R3 28.33
  • R2 28.33
  • R1 28.33
  • S1 28.33
  • S2 28.33
  • S3 28.33

Omkar Pharmachem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-05-29 Audited Results
2025-02-14 Quarterly Results
2024-11-12 Quarterly Results

Omkar Pharmachem F&O

Omkar Pharmachem Shareholding Pattern

0.03%
98.36%
1.61%

About Omkar Pharmachem

  • NSE Symbol
  • OMKARPH
  • BSE Symbol
  • 532167
  • Managing Director
  • Mr. Bhawani Shankar Goyal
  • ISIN
  • INE501C01015

Similar Stocks to Omkar Pharmachem

Omkar Pharmachem FAQs

Omkar Pharmachem share price is ₹28 As on 08 December, 2025 | 09:54

The Market Cap of Omkar Pharmachem is ₹28.6 Cr As on 08 December, 2025 | 09:54

The P/E ratio of Omkar Pharmachem is 203.1 As on 08 December, 2025 | 09:54

The PB ratio of Omkar Pharmachem is 3 As on 08 December, 2025 | 09:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23